CHASE WILLIAM J (CIK 1563572) reported 11 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-07-16). Recent activity: Buy GRAL (276 shares), Buy GRAL (5,491 shares), Buy NTLA (9,200 shares), Buy GRAL (408 shares), Buy GRAL (213 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-16 | GRAIL, Inc. (GRAL) | Director | Buy | 276 | $20,523 |
| 2026-06-22 | GRAIL, Inc. (GRAL) | Director | Buy | 5,491 | $349,996 |
| 2026-06-10 | Intellia Therapeutics, Inc. (NTLA) | Director | Buy | 9,200 | $0 |
| 2026-04-17 | GRAIL, Inc. (GRAL) | Director | Buy | 408 | $20,314 |
| 2026-01-16 | GRAIL, Inc. (GRAL) | Director | Buy | 213 | $20,755 |
| 2025-10-16 | GRAIL, Inc. (GRAL) | Director | Buy | 275 | $20,768 |
| 2025-08-22 | Intellia Therapeutics, Inc. (NTLA) | Director | Buy | 100,000 | $1.0M |
| 2025-07-17 | GRAIL, Inc. (GRAL) | Director | Buy | 533 | $20,536 |
| 2025-06-13 | Intellia Therapeutics, Inc. (NTLA) | Director | Buy | 8,000 | $0 |
| 2025-05-30 | GRAIL, Inc. (GRAL) | Director | Buy | 6,082 | $249,970 |
| 2025-04-16 | GRAIL, Inc. (GRAL) | Director | Buy | 784 | $20,337 |
Source: SEC Form 4 filings · as of 2026-07-16